Effect of phage therapy on the turnover and function of peripheral neutrophils

FEMS Immunology and Medical Microbiology

Volumn 34, Issue 2, 2002, Pages 135-138

  Weber D, Beata ^a   Zimecki, Micha ^a   Mulczyk, Marian ^a   Górski, Andrzej ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Neutrophil precursors; Phage therapy; Phagocytosis; Staphylococcus aureus

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD DONOR; CELL FUNCTION; CELLULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PHAGE THERAPY; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STEM CELL; TREATMENT OUTCOME;

ADULT; AGED; BACTERIAL INFECTIONS; BACTERIOPHAGES; BASOPHILS; EOSINOPHILS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; TIME FACTORS;

EID: 0037063975     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00375-9     Document Type: Article

References (19)

1. Carlton R.M. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. 47:1999;267-274.
2. Weber-Da̧browska B., Mulczyk M., Górski A. Bacteriophage therapy of bacterial infections: an update of our Institute's experience. Arch. Immunol. Ther. Exp. 48:2000;547-551.
3. Weber-Da̧browska B., Zimecki M., Mulczyk M. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp. 48:2000;31-37.
4. Maloney M., Patt H.M. Granulocyte transit from bone-marrow to blood. Blood. 31:1968;195-201.
5. Bainton D.F., Ullyot J., Farguhar M. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J. Exp. Med. 134:1971;907-934.
6. Fliedner T.M., Cronkite S.A., Robertson J.S. Granulocytopoiesis. I. Senescence and random loss of neutrophilic granulocytes. Blood. 24:1964;402-414.
7. Hosker H.S.R., Kelly C., Corris P.A. Assessment of phagocytic function using chemiluminescence. Blood Rev. 3:1989;88-93.
8. Shasby D.M., Vanbenthuysen K.M., Tate R.M., et al. Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phosbol myristate acetate: role of oxygen radicals. Am. Rev. Resp. Dis. 125:1982;443-447.
9. Belaaouaj A., Mc Carthy R., Baumann M., et al. Mice lacking neutrophil elastaze reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4:1998;615-618.
10. Cassatella M.A. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today. 16:1995;21-26.
11. Tchórzewski H. Do granulocytes express the immunoregulatory functions? Arch. Immunol. Ther. Exp. 40:1992;5-9.
12. Ślopek S., Kucharewicz-Krukowska A., Weber-Da̧browska B., Da̧browski M. Results of bacteriophage treatment of suppurative bacterial infections. IV Evaluation of the results obtained in 370 cases. Arch. Immuno. Ther. Exp. 33:1985;219-240.
13. Repine J.E., Clawson C.C., Goetz F.C. Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics. J. Infect. Dis. 142:1980;869-875.
14. Chastel C., Youinan P., Leglise M.C., L'Ifostis D., Ferec C. Dissociated impairment of neutrophil function and recurrent infections. Infection. 10:1982;125-127.
15. Faden H., Hong J.J., Ogra P.L. In vivo effects of clindamycin on neutrophil function. J. Antimicrob. Chemother. Nov. 16:(5):1985;649-657.
16. Gemmel C.G. Does the appearance of drug resistance during therapy after bacterial susceptibility to opsonophagocytosis? Drugs Exp. Clin. Res. 22:1996;51-55.
17. Wenisch C., Parschalk B., Hasenhundl M., Wiesinger E., Graninger W. Effect of cefodizime and seftriaxone on phagocytic function in patients with severe infections. Antimicrob. Agents Chemother. 39:1995;672-676.
18. Ciepichał J., Kübler A. Effect of general and regional anesthesia on some neutrophil functions. Arch. Immunol. Ther. Exp., 46:1998;183-192.
19. Rich I.N. The macrophage as a production site for hematopoietic regulator molecule: sensing and responding to normal and pathophysiological signals. Anticancer Res. 8:1988;105-1040.